At Cahaba Research, Inc., our mission is to bring clinical research to as many lives as possible. Our sole focus is on clinical research, which means that all of our clinical trial partners -- including participants, sponsors, and investigators -- can count on us for unparalleled service and exceptional performance across our network.
Dr. Michael Vaughn, President and CEO, has more than 15 years of experience in clinical research and has been influential in guiding the company's growth and development.
Our current clinical trials
- Arthritis of the Knee
- Hypogonadism (Low Testosterone)
Who can participate in a clinical trial?
While the eligibility criteria can vary from study to study, the general criteria might include:
- A patient’s overall health
- Age and gender
- Body mass index or BMI
- Results of medical tests
- Medications being taken
- Any other health conditions
- Whether a patient has the specific condition being studied
- Other treatments the patient may have had
- How long it has been since the patient was last treated
What is the process for a clinical trial?
The length of a pharmaceutical trial can also vary from study to study, but the overall process is usually the same and will include:
- Screening appointment
- Confirmation phone call
- Baseline/randomization visit
- Study visits
- End of study
Every clinical trial in the U.S. must be approved and monitored by an Institutional Review Board or (IRB) to make sure the risks are as low as possible and are worth any potential benefits.
Cahaba Research FAQs
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help researchers answer different questions.
- Phase I trial – The first evaluation of an experimental drug or treatment in a small group of people (20–80). The purpose is to evaluate its safety and identify side effects.
- Phase II trial – The experimental drug or treatment is administered to a larger group of people (100–300) to determine its effectiveness and to further evaluate its safety.
- Phase III trial – The experimental drug or treatment is administered to large groups of people (1,000–3,000) to confirm its effectiveness, monitor side effects and compare it with standard or equivalent treatments.
- Phase IV trial – After a drug is licensed and approved by the FDA, researchers track its safety, seeking more information about its risks, benefits and optimal use.
There are many benefits to participating in a clinical trial with Cahaba Research, including:
- Financial compensation
- Have access to a new medical treatment before anyone else
- Help doctors and scientists better understand a disease, how it affects our health and how best to treat it
- Help move science and medicine forward to improve the health of others in your community